Germline mutations in BRCA2

Shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia

John E. Wagner, Jakub Tolar, Orna Levran, Thomas Scholl, Amie Deffenbaugh, Jaya Satagopan, Leah Ben-Porat, Katherine Mah, Sat Dev Batish, David I. Kutler, Margaret L. MacMillan, Helmut Hanenberg, Arleen D. Auerbach

Research output: Contribution to journalArticle

133 Citations (Scopus)

Abstract

The breast cancer susceptibility gene BRCA2 has recently been identified as identical to the Fanconi anemia (FA) gene FANCD1. Here we expand the clinical implications of this discovery. Notably, we identified 6 children in 5 kindreds exhibiting the co-occurrence of BRCA2 mutations, FA, and early onset acute leukemia. Leukemia occurred at a median of 2.2 years of age in the BRCA2 patients in contrast to a median onset of 13.4 years in all other FA patients in the International Fanconi Anemia Registry (IFAR; P <.0001). Breast cancer was noted In 4 of the 5 kindreds. Of the 6 children with leukemia, 4 were treated with bone marrow transplantation and 2 are alive at 3 and 9 months after treatment. Our results suggest that BRCA2 testing should be considered in all patients with FA in whom the complementation group cannot be defined or in whom leukemia is diagnosed at or before 5 years of age.

Original languageEnglish (US)
Pages (from-to)3226-3229
Number of pages4
JournalBlood
Volume103
Issue number8
DOIs
StatePublished - Apr 15 2004
Externally publishedYes

Fingerprint

Fanconi Anemia
Germ-Line Mutation
Genetic Predisposition to Disease
Leukemia
Genes
Breast Neoplasms
Bone
Testing
Neoplasm Genes
Bone Marrow Transplantation
Registries
Mutation

ASJC Scopus subject areas

  • Hematology

Cite this

Wagner, J. E., Tolar, J., Levran, O., Scholl, T., Deffenbaugh, A., Satagopan, J., ... Auerbach, A. D. (2004). Germline mutations in BRCA2: Shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia. Blood, 103(8), 3226-3229. https://doi.org/10.1182/blood-2003-09-3138

Germline mutations in BRCA2 : Shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia. / Wagner, John E.; Tolar, Jakub; Levran, Orna; Scholl, Thomas; Deffenbaugh, Amie; Satagopan, Jaya; Ben-Porat, Leah; Mah, Katherine; Batish, Sat Dev; Kutler, David I.; MacMillan, Margaret L.; Hanenberg, Helmut; Auerbach, Arleen D.

In: Blood, Vol. 103, No. 8, 15.04.2004, p. 3226-3229.

Research output: Contribution to journalArticle

Wagner, JE, Tolar, J, Levran, O, Scholl, T, Deffenbaugh, A, Satagopan, J, Ben-Porat, L, Mah, K, Batish, SD, Kutler, DI, MacMillan, ML, Hanenberg, H & Auerbach, AD 2004, 'Germline mutations in BRCA2: Shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia', Blood, vol. 103, no. 8, pp. 3226-3229. https://doi.org/10.1182/blood-2003-09-3138
Wagner, John E. ; Tolar, Jakub ; Levran, Orna ; Scholl, Thomas ; Deffenbaugh, Amie ; Satagopan, Jaya ; Ben-Porat, Leah ; Mah, Katherine ; Batish, Sat Dev ; Kutler, David I. ; MacMillan, Margaret L. ; Hanenberg, Helmut ; Auerbach, Arleen D. / Germline mutations in BRCA2 : Shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia. In: Blood. 2004 ; Vol. 103, No. 8. pp. 3226-3229.
@article{7a647abb6570446a99e57a1bbd62d3ac,
title = "Germline mutations in BRCA2: Shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia",
abstract = "The breast cancer susceptibility gene BRCA2 has recently been identified as identical to the Fanconi anemia (FA) gene FANCD1. Here we expand the clinical implications of this discovery. Notably, we identified 6 children in 5 kindreds exhibiting the co-occurrence of BRCA2 mutations, FA, and early onset acute leukemia. Leukemia occurred at a median of 2.2 years of age in the BRCA2 patients in contrast to a median onset of 13.4 years in all other FA patients in the International Fanconi Anemia Registry (IFAR; P <.0001). Breast cancer was noted In 4 of the 5 kindreds. Of the 6 children with leukemia, 4 were treated with bone marrow transplantation and 2 are alive at 3 and 9 months after treatment. Our results suggest that BRCA2 testing should be considered in all patients with FA in whom the complementation group cannot be defined or in whom leukemia is diagnosed at or before 5 years of age.",
author = "Wagner, {John E.} and Jakub Tolar and Orna Levran and Thomas Scholl and Amie Deffenbaugh and Jaya Satagopan and Leah Ben-Porat and Katherine Mah and Batish, {Sat Dev} and Kutler, {David I.} and MacMillan, {Margaret L.} and Helmut Hanenberg and Auerbach, {Arleen D.}",
year = "2004",
month = "4",
day = "15",
doi = "10.1182/blood-2003-09-3138",
language = "English (US)",
volume = "103",
pages = "3226--3229",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "8",

}

TY - JOUR

T1 - Germline mutations in BRCA2

T2 - Shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia

AU - Wagner, John E.

AU - Tolar, Jakub

AU - Levran, Orna

AU - Scholl, Thomas

AU - Deffenbaugh, Amie

AU - Satagopan, Jaya

AU - Ben-Porat, Leah

AU - Mah, Katherine

AU - Batish, Sat Dev

AU - Kutler, David I.

AU - MacMillan, Margaret L.

AU - Hanenberg, Helmut

AU - Auerbach, Arleen D.

PY - 2004/4/15

Y1 - 2004/4/15

N2 - The breast cancer susceptibility gene BRCA2 has recently been identified as identical to the Fanconi anemia (FA) gene FANCD1. Here we expand the clinical implications of this discovery. Notably, we identified 6 children in 5 kindreds exhibiting the co-occurrence of BRCA2 mutations, FA, and early onset acute leukemia. Leukemia occurred at a median of 2.2 years of age in the BRCA2 patients in contrast to a median onset of 13.4 years in all other FA patients in the International Fanconi Anemia Registry (IFAR; P <.0001). Breast cancer was noted In 4 of the 5 kindreds. Of the 6 children with leukemia, 4 were treated with bone marrow transplantation and 2 are alive at 3 and 9 months after treatment. Our results suggest that BRCA2 testing should be considered in all patients with FA in whom the complementation group cannot be defined or in whom leukemia is diagnosed at or before 5 years of age.

AB - The breast cancer susceptibility gene BRCA2 has recently been identified as identical to the Fanconi anemia (FA) gene FANCD1. Here we expand the clinical implications of this discovery. Notably, we identified 6 children in 5 kindreds exhibiting the co-occurrence of BRCA2 mutations, FA, and early onset acute leukemia. Leukemia occurred at a median of 2.2 years of age in the BRCA2 patients in contrast to a median onset of 13.4 years in all other FA patients in the International Fanconi Anemia Registry (IFAR; P <.0001). Breast cancer was noted In 4 of the 5 kindreds. Of the 6 children with leukemia, 4 were treated with bone marrow transplantation and 2 are alive at 3 and 9 months after treatment. Our results suggest that BRCA2 testing should be considered in all patients with FA in whom the complementation group cannot be defined or in whom leukemia is diagnosed at or before 5 years of age.

UR - http://www.scopus.com/inward/record.url?scp=11144353924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11144353924&partnerID=8YFLogxK

U2 - 10.1182/blood-2003-09-3138

DO - 10.1182/blood-2003-09-3138

M3 - Article

VL - 103

SP - 3226

EP - 3229

JO - Blood

JF - Blood

SN - 0006-4971

IS - 8

ER -